Sale!

SCN1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 1 Genetic Test

4,400 د.إ

-21%

The SCN1B gene is associated with a condition known as Generalized Epilepsy with Febrile Seizures Plus Type 1 (GEFS+1). This genetic disorder is characterized by a broad spectrum of seizure types that can vary significantly in severity among affected individuals. The SCN1B gene plays a crucial role in the functioning of sodium channels in the brain, which are essential for the proper transmission of electrical signals. Mutations in the SCN1B gene can disrupt these channels, leading to the development of epilepsy and related seizure disorders.

To diagnose this condition and understand its genetic basis, a specialized genetic test targeting the SCN1B gene can be conducted. At DNA Labs UAE, this test is available for individuals who may be at risk of GEFS+1 due to their family history or for those who exhibit symptoms suggestive of this condition. The test involves analyzing the DNA to identify mutations in the SCN1B gene that are known to be associated with the disorder.

The cost of the SCN1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 1 Genetic Test at DNA Labs UAE is 4400 AED. The test provides valuable information that can aid in the diagnosis and management of the condition, enabling healthcare providers to tailor treatment plans more effectively for those affected. Additionally, understanding the genetic underpinnings of GEFS+1 can offer insights into potential risks for family members and inform decisions regarding genetic counseling.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SCN1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 1 Genetic Test

At DNA Labs UAE, we offer the SCN1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 1 Genetic Test. This test is designed to diagnose and provide information about Generalized Epilepsy with Febrile Seizures Plus Type 1 (GEFS+), a genetic disorder associated with the SCN1B gene.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the SCN1B Gene Generalized Epilepsy with Febrile Seizures Plus Type 1 Genetic Test, it is important to provide the clinical history of the patient. A genetic counseling session will also be conducted to draw a pedigree chart of family members affected with GEFS+.

Test Details

The SCN1B gene is responsible for the development of Generalized Epilepsy with Febrile Seizures Plus Type 1. This genetic disorder causes seizures, often triggered by fever, and can also lead to other types of seizures, developmental delays, and cognitive impairments.

Our NGS (Next-Generation Sequencing) genetic testing method allows us to identify mutations in the SCN1B gene and other genes associated with GEFS+. By sequencing the patient’s DNA, we can identify any genetic variations that may be causing their symptoms. This information is crucial in developing personalized treatment plans and providing genetic counseling to patients and their families.

Test Name SCN1B Gene Generalized epilepsy with febrile seizures plus type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SCN1B Gene Generalized epilepsy with febrile seizures plus type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN1B Gene Generalized epilepsy with febrile seizures plus type 1
Test Details

The SCN1B gene is associated with the development of Generalized Epilepsy with Febrile Seizures Plus Type 1 (GEFS+). This is a genetic disorder that causes seizures, often triggered by fever, and can also lead to other types of seizures, developmental delays, and cognitive impairments.

NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool that can identify mutations in the SCN1B gene and other genes associated with GEFS+. This test involves sequencing the patient’s DNA to identify any genetic variations that may be causing their symptoms. This information can help doctors develop personalized treatment plans and provide genetic counseling to patients and their families.